Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deoxyhypusine synthase (DHPS) is an essential enzyme that catalyzes the first step in the post-translational modification of eukaryotic initiation factor 5A (eIF5A), specifically forming deoxyhypusine, a precursor to hypusine—a unique amino acid found only in eIF5A. This modification is critical for the activation and function of eIF5A, which plays a central role in mRNA translation and cellular growth. DHPS is considered a therapeutic target in cancer, diabetes, and infectious diseases.
Inhibition of DHPS leads to reduced hypusination of eIF5A, thereby impairing mRNA translation and cellular growth/division.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyhypusine synthase (DHPS).